SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Maxim Group Upgrades Co-Diagnostics to Buy, Announces $30 Price Target

Maxim Group upgrades Co-Diagnostics (NASDAQ:CODX) from Hold to Buy and announces $30 price target.

Benzinga · 05/20/2020 11:42

Maxim Group upgrades Co-Diagnostics (NASDAQ:CODX) from Hold to Buy and announces $30 price target.